Although we excluded this trial from our review because of study participants with severe comorbidities, it supports the findings of our subgroup analysis indicating increased BCG-mediated NSE for respiratory infections in participants with impaired health. The gene discussed is ENO2; the disease is respiratory tract infectious disorder.